Evidence map›Paper›PMID 41021020›Full record

ArticleUrolithiasis2025

Variants of unknown significance are common in brushite stone formers undergoing genetic testing for nephrolithiasis.

Tomas Paneque, Kyle Berst, Meenakshi Sambharia, Melissa Swee, Mycah Kimble, M Adela Mansilla, Margaret Freese, Christie P Thomas, Chad R Tracy, Ryan L Steinberg

Abstract read
In one paragraph

Article in Urolithiasis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tomas PanequeDepartment of Urology, University of Iowa Health Care, 200 Hawkins Drive, 3RCP, Iowa City, IA, 52242, USA.
Kyle BerstCarver College of Medicine, University of Iowa, Iowa City, IA, USA.
Meenakshi SambhariaDepartment of Internal Medicine, University of Iowa Health Care, Iowa City, IA, USA.
Melissa SweeDepartment of Internal Medicine, University of Iowa Health Care, Iowa City, IA, USA.
Mycah KimbleIowa Institute for Human Genetics, University of Iowa, Iowa City, IA, USA.
M Adela MansillaIowa Institute for Human Genetics, University of Iowa, Iowa City, IA, USA.
Margaret FreeseIowa Institute for Human Genetics, University of Iowa, Iowa City, IA, USA.
Christie P ThomasDepartment of Internal Medicine, University of Iowa Health Care, Iowa City, IA, USA.
Chad R TracyDepartment of Urology, University of Iowa Health Care, 200 Hawkins Drive, 3RCP, Iowa City, IA, 52242, USA.
Ryan L SteinbergDepartment of Urology, University of Iowa Health Care, 200 Hawkins Drive, 3RCP, Iowa City, IA, 52242, USA. ryan-steinberg@uiowa.edu.

Funding

University of Iowa Institute for Clinical and Translational ScienceUM1TR004403 · NCATS · UNIVERSITY OF IOWA · PI Marlan R Hansen, Patricia Winokur · 2023 to 2026
$16.1M
National Center for Advancing Translational Sciences of the National Institutes of Health UM1TR004403NCATS NIH HHS UM1 TR004403
6 · The paper itself

Abstract

Up to 40% of all kidney stone disease may have an underlying genetic contribution. Brushite stone formers are known to have high rates of stone recurrence and urine chemistry abnormalities, suggesting a possible intrinsic kidney abnormality which may contribute to brushite stone formation. In this study, we sought to determine the burden of genetic variants amongst brushite stone formers. An IRB approved prospective study of brushite stone formers was conducted. Patients with any brushite on stone analysis were eligible for enrollment. Genetic testing was done on peripheral blood derived DNA and assessed using a clinically available nephrolithiasis gene panel. Primary analysis assessed rates of genetic variants amongst brushite stone formers. Secondary analysis assessed for distinct patterns in urine chemistries in different genotypes. 15 patients (8 males) with a median age of 32 years (range 22-69) underwent genetic testing. 12 patients (80%) were reported to have a genetic variant, with 6 (40%) having multiple variants. Two patients had a heterozygous pathogenic or likely pathogenic variant in a gene that causes autosomal recessive disease. 9 (60%) patients had a variant of unknown significance. 10 (67%) patients had genetic variants associated with hypophosphatemic rickets. Genetic variants of unknown significance are common in brushite stone formers. Further work is needed to assess the significance of these variants and their role in the lithogenic process.

Indexed as

Calcium PhosphatesKidney CalculiNephrolithiasisAdultAgedFemaleGenetic TestingGenetic VariationHumansMaleMiddle AgedProspective StudiesYoung Adultcalcium phosphate, dibasic, dihydrateCalcium PhosphatesBrushiteGeneticsHypophosphatemic ricketsKidney stones

Identifiers

PMID41021020
PMCPMC12479612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.